26 Sitagliptin was compared with saxagliptin (Onglyza, Bristol-Myers Squibb/AstraZeneca) in an 18-week, double-blind, non-inferiority trial
That could be the sustained release that I mentioned earlier, where you add something to the formulation and then it sticks on the injection side
Current formulations of GLP-1 analogs rely primarily on subcutaneous injections, which may pose challenges to patient convenience and long-term adherence
If you are dealing with constipation on tirzepatide that fiber supplements have not resolved, low potassium could be the underlying cause
Cost alone does not reflect clinical value
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the global burden of disease study 2017